Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Stenocare

1.25 DKK

-7.41 %

Less than 1K followers

STENO

First North Denmark

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-7.41 %
-11.35 %
-15.54 %
-26.47 %
-1.19 %
+188.02 %
-73.92 %
-86.84 %
-90.84 %

Stenocare is a Danish supplier of medical cannabis. Stenocare is the first player to have started sale of medical cannabis-based oils in Denmark. The company is now looking towards further European markets for its products. Stenocare is based in Randers, Denmark.

Read more
Market cap
54.25M DKK
Turnover
402.07K DKK
Revenue
7.02M
EBIT %
-25.26 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

All
Press releases
3rd party
ShowingAll content types
Press release2/26/2026, 2:54 PM

Analyst Group: Analyst Group Comment on STENOCARE’s Q4-report 2025

Stenocare
Regulatory press release2/26/2026, 7:00 AM

STENOCARE: Interim report fourth quarter and Financial Statement Release 2025

Stenocare
Press release2/11/2026, 8:25 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Partnership with ICMF and Product Filing in France

Stenocare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/11/2026, 7:00 AM

STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partnership

Stenocare
Press release1/28/2026, 8:28 AM

Analyst Group: Analyst Group Comment on STENOCAREs partnership with WEECO and Launch of a New Astrum Oil Product in Germany

Stenocare
Press release1/27/2026, 3:27 PM

STENOCARE: Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany

Stenocare
Regulatory press release12/30/2025, 10:19 AM

Trading in STENOCARE shares by closely related party to board member

Stenocare
Press release11/21/2025, 5:41 AM

BioStock: Stenocare förvärvar Canngros

Stenocare
Press release11/21/2025, 5:41 AM

BioStock: Stenocare acquires Canngros

Stenocare
Press release11/19/2025, 6:56 PM

STENOCARE share analyst's comments on the CannGros acquisition

Stenocare
Press release11/18/2025, 11:18 AM

Analyst Group: Analyst Group Comment on STENOCAREs acquisition of CannGros ApS

Stenocare
Regulatory press release11/18/2025, 8:59 AM

STENOCARE: Correction of total shares issued and total nominal share capital:

Stenocare
Regulatory press release11/17/2025, 4:56 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Regulatory press release11/17/2025, 4:01 PM

STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal

Stenocare
Press release10/24/2025, 12:31 PM

Analyst Group: Equity Research Report on STENOCARE - Transforms to a Profitable Growth Company

Stenocare
Press release10/22/2025, 12:54 PM

Analyst Group: Analyst Group Comment on STENOCARE’s Q3-report 2025

Stenocare
Regulatory press release10/22/2025, 6:00 AM

STENOCARE: Interim report third quarter 2025

Stenocare
Press release8/29/2025, 1:10 PM

Analyst Group: Equity Research Report on STENOCARE - Capitalizes on STENOCARE 3.0

Stenocare
Regulatory press release8/27/2025, 7:30 PM

Trading in STENOCARE shares by closely related party to board member

Stenocare
Press release8/21/2025, 10:50 AM

Analyst Group: Analyst Group Comment on STENOCARE’s Q2-report 2025

Stenocare
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.